Loading company…
Oklahoma City preclinical biopharmaceutical company developing a glucose-responsive insulin for people with diabetes.
Sensulin, LLC is a preclinical biopharmaceutical company developing a glucose-responsive insulin intended to reduce hypoglycemia risk and help manage type 1 and type 2 diabetes. Founded in 2011 and headquartered in Oklahoma City, US, the company is at the Seed stage. Its October 2021 round raised USD 2.70 mn in a Series A, and Chris Rhodes is the founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in